$75 Million

Axovant Gene Therapies Ltd.

At-the-market Offering

Axovant Gene Therapies, part of the Roivant family of companies, is a clinical-stage gene therapy company focused on developing a pipeline of innovative product candidates for debilitating neurodegenerative diseases.